NO753158L - - Google Patents
Info
- Publication number
- NO753158L NO753158L NO753158A NO753158A NO753158L NO 753158 L NO753158 L NO 753158L NO 753158 A NO753158 A NO 753158A NO 753158 A NO753158 A NO 753158A NO 753158 L NO753158 L NO 753158L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- acetylsalicylic acid
- hydrogen atom
- same
- alkyl group
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 23
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 229940068372 acetyl salicylate Drugs 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- ZIOBGZDFMKCKGZ-UHFFFAOYSA-N 2-amino-2-methylpropanamide Chemical compound CC(C)(N)C(N)=O ZIOBGZDFMKCKGZ-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 4
- GQEXBJOPGJUKIL-UHFFFAOYSA-N 1-aminocyclohexane-1-carboxamide Chemical compound NC(=O)C1(N)CCCCC1 GQEXBJOPGJUKIL-UHFFFAOYSA-N 0.000 description 3
- OPSUSMMZNXNXKD-UHFFFAOYSA-N 2-(dimethylamino)-2-methylpropanamide Chemical compound CN(C)C(C)(C)C(N)=O OPSUSMMZNXNXKD-UHFFFAOYSA-N 0.000 description 3
- YTSVIBZGAFTNCI-UHFFFAOYSA-N 2-methyl-2-(methylamino)propanamide Chemical compound CNC(C)(C)C(N)=O YTSVIBZGAFTNCI-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 3
- XIMBESZRBTVIOD-UHFFFAOYSA-N piperidine-2-carboxamide Chemical compound NC(=O)C1CCCCN1 XIMBESZRBTVIOD-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7431400A FR2285141A1 (fr) | 1974-09-17 | 1974-09-17 | Nouveau derive de l'acide acetylsalicylique, sa preparation et les compositions qui le contiennent |
| FR7520099A FR2315279A1 (fr) | 1975-06-26 | 1975-06-26 | Nouveaux derives de l'acide acetylsalicylique, leur preparation et les compositions qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO753158L true NO753158L (it) | 1976-03-18 |
Family
ID=26218517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO753158A NO753158L (it) | 1974-09-17 | 1975-09-16 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5161615A (it) |
| AT (1) | AT339886B (it) |
| AU (1) | AU8484975A (it) |
| CH (1) | CH593234A5 (it) |
| DE (1) | DE2541475A1 (it) |
| ES (1) | ES441029A1 (it) |
| FI (1) | FI752589A (it) |
| GB (1) | GB1476026A (it) |
| HU (1) | HU172524B (it) |
| IL (1) | IL48108A0 (it) |
| LU (1) | LU73412A1 (it) |
| NL (1) | NL7510622A (it) |
| NO (1) | NO753158L (it) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU185926B (en) * | 1979-09-27 | 1985-04-28 | Agostne Kahan | Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives |
| JPS5742680A (en) * | 1980-08-29 | 1982-03-10 | Bago Sa Labor | Novel ester of substituted benzoic acid and manufacture |
-
1975
- 1975-09-09 NL NL7510622A patent/NL7510622A/xx not_active Application Discontinuation
- 1975-09-15 HU HU75RO00000854A patent/HU172524B/hu unknown
- 1975-09-15 AU AU84849/75A patent/AU8484975A/en not_active Expired
- 1975-09-16 CH CH1197375A patent/CH593234A5/xx not_active IP Right Cessation
- 1975-09-16 NO NO753158A patent/NO753158L/no unknown
- 1975-09-16 LU LU73412A patent/LU73412A1/xx unknown
- 1975-09-16 IL IL48108A patent/IL48108A0/xx unknown
- 1975-09-16 JP JP50111023A patent/JPS5161615A/ja active Pending
- 1975-09-17 ES ES441029A patent/ES441029A1/es not_active Expired
- 1975-09-17 DE DE19752541475 patent/DE2541475A1/de active Pending
- 1975-09-17 GB GB3823075A patent/GB1476026A/en not_active Expired
- 1975-09-17 AT AT713675A patent/AT339886B/de active
- 1975-09-17 FI FI752589A patent/FI752589A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL48108A0 (en) | 1975-11-25 |
| ES441029A1 (es) | 1977-03-01 |
| AU8484975A (en) | 1977-03-24 |
| JPS5161615A (it) | 1976-05-28 |
| NL7510622A (nl) | 1976-03-19 |
| LU73412A1 (it) | 1976-08-13 |
| ATA713675A (de) | 1977-03-15 |
| CH593234A5 (it) | 1977-11-30 |
| HU172524B (hu) | 1978-09-28 |
| GB1476026A (en) | 1977-06-10 |
| DE2541475A1 (de) | 1976-03-25 |
| AT339886B (de) | 1977-11-10 |
| FI752589A (it) | 1976-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bentiss et al. | A new synthesis of symmetrical 2, 5‐disubstituted 1, 3, 4‐oxadiazoles | |
| SU451244A3 (ru) | Способ получени производных фенилимидазолилалкила | |
| DE2845499A1 (de) | Alkanoylprolin-derivate und deren homologen, ihre herstellung und verwendung | |
| Haake et al. | Kinetic Studies of the Decarboxylation of Some N-Substituted Pyridinecarboxylic Acids | |
| US2453103A (en) | Decarboxylation of 3,4-dihydroxy-2,5-dicarboxythiophene | |
| SU718009A3 (ru) | Способ получени 1-нитро-9-алкиламиноалкиламинакридинов или их солей | |
| US4224457A (en) | Process for manufacturing optically active sulfur-containing carboxylic acid | |
| JPS6178778A (ja) | ４，５‐ジヒドロ‐４‐オキソ‐２‐〔（２‐ｔｒａｎｓ‐フエニルシクロプロピル）アミノ〕‐３‐フランカルボン酸とその誘導体 | |
| Galat | Synthesis of papaverine and some related compounds | |
| NO753158L (it) | ||
| SU567404A3 (ru) | Способ получени производных 2-нитроимидазола | |
| Beyerman et al. | A convenient synthesis of L‐1‐methylhistidine and L‐1‐ethylhistidine | |
| US3705895A (en) | Process for the direct synthesis of styrylpyridinium chlorides | |
| SU845778A3 (ru) | Способ получени 5-фенил-1н-бензазепиновили иХ СОлЕй | |
| US2557284A (en) | Esters of pantothenic acid, intermediates thereof, and process for their production | |
| US3244725A (en) | 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones | |
| US2655507A (en) | Pyrazole compounds | |
| US2655508A (en) | Pyrazole compound | |
| US2135521A (en) | Homologues of beta-methylcholine halide and their acyl derivatives, and processes for their production | |
| US3109022A (en) | Nu-aryl anthranilic acids | |
| SU528878A3 (ru) | Способ получени производных (гетероарилметил)-дезоксинорморфина или- дезоксиноркодеина, или их солей | |
| US2374367A (en) | Process for preparing therapeutically active substances | |
| US3711551A (en) | Process of producing ortho-aminophenol | |
| SU368265A1 (ru) | Способ получения 4-алкил-5,6-диоксипиразоло- | |
| SU390088A1 (ru) | Способ получения эфиров |